Glucagon-like Peptide-1 Receptor Agonist Use is Associated With Increased Risk of Perioperative Complication and Readmission Following Shoulder Arthroplasty.
Glucagon-like Peptide-1 受體激動劑的使用與肩關節置換術後圍手術併發症和再入院風險增加相關。
J Shoulder Elbow Surg 2024-11-11
The Impact of Glucagon-Like Peptide-1 Agonists on Hip and Knee Arthroplasty and Perioperative Considerations.
GLP-1激動劑對髖膝關節置換術的影響及围手术期考量。
J Arthroplasty 2024-05-15
Decreased Risk of Readmission and Complications with Preoperative GLP-1 Analog Use in Patients Undergoing Primary Total Joint Arthroplasty.
接受初次全關節置換手術的患者，在術前使用 GLP-1 類似物可降低再入院和併發症的風險。
J Arthroplasty 2024-06-01
The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis.
在接受麻醉或鎮靜的患者中，胰高血糖素樣肽-1受體激動劑的影響：系統性回顧與統合分析。
Perioper Med (Lond) 2024-07-22
GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study.
GLP-1 受體激動劑與腹腔鏡袖狀胃切除術後噁心與嘔吐風險：單中心回顧性隊列研究。
Surg Obes Relat Dis 2024-10-31
Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated with Increased Complications After Total Hip Arthroplasty in Patients Who Have Type-2 Diabetes.
在患有2型糖尿病的患者中，使用胰高血糖素樣肽-1受體激動劑與全髖關節置換術後併發症增加無關。
J Arthroplasty 2024-11-01
Lower Risk of Postoperative Complications and Rotator Cuff Retear Associated with Semaglutide Use in Patients with Type II Diabetes Mellitus Undergoing Arthroscopic Rotator Cuff Repair.
使用 Semaglutide 的 II 型糖尿病患者在接受關節鏡肩袖修復手術後，較低的術後併發症風險和肩袖再撕裂風險。
Arthroscopy 2024-11-03
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?
GLP-1 受體激動劑的範疇回顧：它們是否與胃內容物增加、逆流和吸入事件相關？
J Clin Med 2024-11-09